VivoSeq
Other

Altitude

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Altitude is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

95/100

Attrition Rate

4/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

24

clinical trials

Completed21 · 88%
Terminated1 · 4%
Active, not recruiting1 · 4%
Unknown status1 · 4%

Trial Activity

24 trials

Pharmacological Countermeasures for High Altitude
Active, not recruiting··Phase 4·NCT05300477·18 enrolled
Pulmonary Surfactant(PS) Therapy at High Altitude Area
Completed··N/A·NCT03440333·400 enrolled
Endurance Performance at Altitude
Completed·UUniversity of British Columbia·N/A·NCT03710369·10 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)